Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen

Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen

Abstract Aim To explore the effect of TEC chemotherapy regimen (Docetaxel + Epirubicin + Cyclophosphamide) on traditional cardiovascular risk factors, atherosclerotic cardiovascular disease and cardiac electrical activity. Design 243 patients with first initially diagnosed breast cancer were collect...

Full description

Bibliographic Details
Main Authors: Zhaoying Dong, Zhaojun Liu, Siyu Chen, Changhong Zhang, Jun Xiao, Xiaoli Zhou
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Nursing Open
Subjects:
breast neoplasms
cardiovascular protection
drug therapy
hyperlipidaemias
hyperuricaemia
Online Access:https://doi.org/10.1002/nop2.1059

Internet

https://doi.org/10.1002/nop2.1059

Similar Items